Xueji Bio

Xueji Bio is a Shanghai-based biotechnology company specializing in advanced organoid technologies for drug discovery and precision medicine. Founded by experts from Fudan University, the company has developed an automated, high-throughput organoid culture and screening platform that integrates microfluidics and organ-on-a-chip systems. Their core business includes providing patient-derived organoid (PDO) models for personalized cancer treatment and large-scale drug sensitivity testing for pharmaceutical partners. By bridging the gap between traditional 2D cell cultures and animal models, Xueji Bio aims to improve the efficiency and predictive accuracy of preclinical drug development. The company is backed by prominent venture capital firms, positioning it as a leader in the emerging organoid-based research sector in China.